阳光肺科
微信扫码登录
30
7
3万
V4
参考文献 Jianming Xu, et al. SCT-I10A combined with a bevacizumab biosimilar (SCT510) versus sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A randomized phase 3 trial. J Clin Oncol 42, 2024 (suppl 16; abstr 4092)
使用道具 举报
给我们建议|手机版|PIME|阳光肺科 ( 粤ICP备2020077405号-1 )
GMT+8, 2024-9-20 08:46
Powered by Discuz! X3.5
© 2001-2024 Discuz! Team.